The vaccine bulk manufacturing is scheduled for 2025 with the delivery of the freeze-dried doses set for 2026.

The African health agency says that Rwanda has started a vaccination campaign against mpox with 1,000 doses it obtained from ...

Mpox vaccines have been administered in Africa for the first time, with several hundred high-risk individuals vaccinated in ...

(RTTNews) - Bavarian Nordic A/S (BAVA) Thursday said that the European Commission has adopted the Committee for Medicinal Products for Human Use (CHMP) recommendation for the approval of a type II ...

In an emulated target trial, a single dose of modified vaccinia Ankara-Bavarian Nordic vaccine was moderately effective in ...

One dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine is moderately effective against mpox infection in ...

The World Health Organization (WHO) has announced the MVA-BN vaccine as the first vaccine against mpox to be added to its prequalification list.

Modified Vaccinia Ankara-Bavarian Nordic or MVA-BN is indicated for active immunisation against smallpox, Mpox, and related orthopoxvirus infections and disease in all adults 18 years of age and older ...

Bavarian Nordic (OTCPK:BVNRY) (OTCPK:BVNKF) on Friday said it received prequalification from the World Health Organization (WHO) for IMVANEX (MVA-BN) as the first mpox vaccine to be added to the ...

WHO – MVA-BN VACCINE CAN BE ADMINISTERED IN PEOPLE OVER 18-YEARS OF AGE AS A 2-DOSE INJECTION GIVEN 4 WEEKS APART ...

The World Health Organization (WHO) said it has added the MVA-BN vaccine as the first vaccine against mpox to be added to its prequalification list. The prequalification approval is expected to ...

(RTTNews) - Bavarian Nordic (BVNKF.PK) announced the company has obtained prequalification from the World Health Organization for IMVANEX, or MVA-BN, as the first mpox vaccine to be added to the ...